We are the combination of four hospitals: the General Hospital, the Children’s Hospital, the Women’s Hospital and the Traumatology, Rehabilitation and Burns Hospital. We are part of the Vall d’Hebron Barcelona Hospital Campus: a world-leading health park where healthcare plays a crucial role.
Below we will list the departments and units that form part of Vall d’Hebron Hospital and the main diseases that we treat. We will also make recommendations based on advice backed up by scientific evidence that has been shown to be effective in guaranteeing well-being and quality of life.
Would you like to know what your stay at Vall d'Hebron will be like? Here you will find all the information.
The commitment of Vall d'Hebron University Hospital to innovation allows us to be at the forefront of medicine, providing first class care adapted to the changing needs of each patient.
Radiotherapy is a type of oncology treatment that uses radiation to eliminate tumour cells from the area of the organism where it is being applied.
Radiotherapy is used to treat some, but not all, types of cancer. Sometimes it is used as the only treatment, other times, in combination with other treatments, such as surgery or chemotherapy. The objective is to reduce the size of the tumour before surgery or to destroy the tumour cells after the surgical procedure.
In order to apply this treatment, the linear accelerator and the cobalt unit are used. For the duration of the treatment, between 1 and 7 weeks, patients must come to the Hospital daily to receive it. During this time, the total dose of radiation is distributed per session. The duration and number of the sessions depends on each individual case.
Radiotherapy acts on the tumour and destroys malignant cells, preventing them from growing and reproducing. This type of treatment is based on the use of ionising radiation and is painless.
Radiotherapy treatment can cause a series of side effects that appear during the course of treatment, in the part of the body that is being treated. They are different in each person, and can be more or less intense. They are stronger if the patient is receiving chemotherapy during radiotherapy. The most frequent effects are changes to skin and tiredness, as well as nausea and vomiting, hair loss in the treated area, inflammation in the mouth, lack of saliva, difficulty in swallowing food, diarrhoea or discomfort while urinating.
Radiotherapy treatment can also cause a series of effects that appear years after treatment and can become chronic. These are infrequent, but can occur. It depends on the part of the body in where the treatment is received, the amount and duration of the radiotherapy and whether chemotherapy was also received.
Some longer-term side effects are: changes in the brain such as loss of memory or difficulty in moving, infertility, arm oedema, changes in the mouth (lack of saliva, tooth decay, bone damage) or secondary tumours.
The acceptance of these terms implies that you give your consent to the processing of your personal data for the provision of the services you request through this portal and, if applicable, to carry out the necessary procedures with the administrations or public entities involved in the processing. You may exercise the mentioned rights by writing to web@vallhebron.cat, clearly indicating in the subject line “Exercise of LOPD rights”. Responsible entity: Vall d’Hebron University Hospital (Catalan Institute of Health). Purpose: Subscription to the Vall d’Hebron Barcelona Hospital Campus newsletter, where you will receive news, activities, and relevant information. Legal basis: Consent of the data subject. Data sharing: If applicable, with VHIR. No other data transfers are foreseen. No international transfer of personal data is foreseen. Rights: Access, rectification, deletion, and data portability, as well as restriction and objection to its processing. The user may revoke their consent at any time. Source: The data subject. Additional information: Additional information can be found at https://hospital.vallhebron.com/es/politica-de-proteccion-de-datos.